Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 3 Sarcoma 1 NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1 Neoplasm Metastasis 1

Interventions

Everolimus 3 tislelizumab 1 surufatinib 1 romidepsin 1 regorafenib 1 pembrolizumab 1 pasireotide 1 lutetium Lu 177 dotatate 1 folfirinox 1 fludarabine phosphate 1 epothilone B 1 cixutumumab 1 Surgical Procedures, Operative 1 Sunitinib 1 Specimen Handling 1 Radiosurgery 1 Octreotide 1 Magnetic Resonance Spectroscopy 1 Liver Transplantation 1 Lactones 1 LY2584702 1 Interleukin-13 1 Granulocyte Colony-Stimulating Factor 1 Fluorodeoxyglucose F18 1 Filgrastim 1 Erlotinib Hydrochloride 1 Embolization, Therapeutic 1 Doxorubicin 1 Depsipeptides 1 Cytokines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Liver Transplantation × NET × Clear all

NCT01201096 2010-09-23

NEO-LEBE

University of Jena

Neoplasm Metastasis, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡